Raj Denhoy
Stock Analyst at Jefferies
(3.03)
# 1,253
Out of 5,154 analysts
55
Total ratings
68.09%
Success rate
24.45%
Average return
Main Sectors:
Stocks Rated by Raj Denhoy
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABT Abbott Laboratories | Reiterates: Hold | $120 | $109.56 | +9.53% | 5 | Sep 26, 2024 | |
| EW Edwards Lifesciences | Maintains: Buy | $110 → $130 | $81.64 | +59.24% | 10 | Jul 30, 2021 | |
| HOLX Hologic | Maintains: Buy | $106 → $110 | $75.74 | +45.23% | 9 | Apr 5, 2021 | |
| PROF Profound Medical | Initiates: Buy | n/a | $5.31 | - | 1 | Sep 15, 2020 | |
| DXCM DexCom | Maintains: Buy | $29 → $31 | $68.10 | -54.11% | 8 | Aug 2, 2018 | |
| AXGN Axogen | Initiates: Buy | $35 | $28.55 | +22.59% | 1 | Nov 30, 2017 | |
| TFX Teleflex | Maintains: Buy | $270 → $295 | $113.31 | +160.35% | 9 | Nov 3, 2017 | |
| LIVN LivaNova | Maintains: Buy | $80 → $91 | $63.84 | +42.54% | 3 | Nov 3, 2017 | |
| LNTH Lantheus Holdings | Maintains: Buy | $22 → $27 | $72.56 | -62.79% | 2 | Nov 3, 2017 | |
| PODD Insulet | Maintains: Buy | $58 → $67 | $237.01 | -71.73% | 7 | Nov 3, 2017 |
Abbott Laboratories
Sep 26, 2024
Reiterates: Hold
Price Target: $120
Current: $109.56
Upside: +9.53%
Edwards Lifesciences
Jul 30, 2021
Maintains: Buy
Price Target: $110 → $130
Current: $81.64
Upside: +59.24%
Hologic
Apr 5, 2021
Maintains: Buy
Price Target: $106 → $110
Current: $75.74
Upside: +45.23%
Profound Medical
Sep 15, 2020
Initiates: Buy
Price Target: n/a
Current: $5.31
Upside: -
DexCom
Aug 2, 2018
Maintains: Buy
Price Target: $29 → $31
Current: $68.10
Upside: -54.11%
Axogen
Nov 30, 2017
Initiates: Buy
Price Target: $35
Current: $28.55
Upside: +22.59%
Teleflex
Nov 3, 2017
Maintains: Buy
Price Target: $270 → $295
Current: $113.31
Upside: +160.35%
LivaNova
Nov 3, 2017
Maintains: Buy
Price Target: $80 → $91
Current: $63.84
Upside: +42.54%
Lantheus Holdings
Nov 3, 2017
Maintains: Buy
Price Target: $22 → $27
Current: $72.56
Upside: -62.79%
Insulet
Nov 3, 2017
Maintains: Buy
Price Target: $58 → $67
Current: $237.01
Upside: -71.73%